Fairman Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.9K Buy
75
+1
+1% +$68 ﹤0.01% 209
2026
Q2
$4.74K Hold
74
– – ﹤0.01% 212
2026
Q1
$5.27K Hold
74
– – ﹤0.01% 194
2025
Q4
$6.07K Buy
74
+72
+3,600% +$5.61K ﹤0.01% 187
2025
Q3
$150 Hold
2
– – ﹤0.01% 266
2025
Q2
$148 Hold
2
– – ﹤0.01% 249
2025
Q1
$156 Hold
2
– – ﹤0.01% 251
2024
Q4
$156 Hold
2
– – ﹤0.01% 338
2024
Q3
$188 Hold
2
– – ﹤0.01% 380
2024
Q2
$156 Hold
2
– – ﹤0.01% 386
2024
Q1
$182 Hold
2
– – ﹤0.01% 380
2023
Q4
$155 Buy
+2
New +$140 ﹤0.01% 378

Other funds holding GEHC

Fairman Group's GEHC Position: Q3 2026 in Review

Fairman Group increased its GE HealthCare (GEHC) stake by 1.4% in Q3 2026, buying an estimated $68 and bringing the position to 75 shares worth $4.9K. The position accounts for ﹤0.01% of the portfolio, ranked #209.

Fairman Group first reported a position in GEHC in Q4 2023 and has held it in 12 quarters since. The position peaked at $6.07K in Q4 2025. 609 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Fairman Group held 75 shares of GE HealthCare worth $4.9K as of Q3 2026.
  • Fairman Group bought 1 GE HealthCare share in Q3 2026, an estimated $68.
  • GE HealthCare made up ﹤0.01% of Fairman Group's portfolio in Q3 2026, its #209 holding.
  • Fairman Group first reported a position in GE HealthCare in Q4 2023 and has held it in 12 quarters since.
  • Fairman Group's GE HealthCare position peaked at $6.07K in Q4 2025.
  • 609 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.